Nephros (NEPH) Income from Non-Controlling Interests (2018 - 2022)
Nephros (NEPH) recorded quarterly Income from Non-Controlling Interests of $70000.0 in Q4 2022, down 9.09% quarter-over-quarter from $77000.0 in Q3 2022, and up 14.75% on a YoY basis from $61000.0 in Q4 2021.
Nephros (NEPH) Income from Non-Controlling Interests (2018 - 2022) Analysis & Trends
Nephros' Income from Non-Controlling Interests history runs 5 years deep, the most recent figure standing at $70000.0 for Q4 2022.
- In Q4 2022, Income from Non-Controlling Interests rose 14.75% year-over-year to $70000.0; the TTM figure through Dec 2022 stood at $276000.0 (up 15.0% YoY), while the FY2022 annual figure was $276000.0, up 15.0% from the prior year.
- Income from Non-Controlling Interests was $70000.0 for Q4 2022 at Nephros, down from $77000.0 in the prior quarter.
- In the past five years, Income from Non-Controlling Interests ranged from a high of $421000.0 in Q4 2019 to a low of -$61000.0 in Q2 2019.
- Historically, Income from Non-Controlling Interests has averaged $59588.2 across 5 years, with a median of $60000.0 in 2020.
- The sharpest annual moves came in 2019 and 2020: Income from Non-Controlling Interests plunged 475.0% in 2019, then surged 200.0% in 2020.
- A 5-year view of Income from Non-Controlling Interests shows it stood at $16000.0 in 2018, then jumped by 2531.25% to $421000.0 in 2019, then slumped by 85.51% to $61000.0 in 2020, then changed by 0.0% to $61000.0 in 2021, then gained by 14.75% to $70000.0 in 2022.
- The last three Income from Non-Controlling Interests figures came in at $70000.0 (Q4 2022), $77000.0 (Q3 2022), and $66000.0 (Q2 2022), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 5.00 Mn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | - |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 105.00 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | - |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | - |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | - |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | - |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | - |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | - |
| 10 | Nephros | 34.19 Mn | 30.17 Mn | 2.99 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 70,000.00 |
| Sep 30, 2022 | 77,000.00 |
| Jun 30, 2022 | 66,000.00 |
| Mar 31, 2022 | 63,000.00 |
| Dec 31, 2021 | 61,000.00 |
| Sep 30, 2021 | 60,000.00 |
| Jun 30, 2021 | 60,000.00 |
| Mar 31, 2021 | 59,000.00 |
| Dec 31, 2020 | 61,000.00 |
| Sep 30, 2020 | 60,000.00 |
| Jun 30, 2020 | 60,000.00 |
| Mar 31, 2020 | 59,000.00 |
| Dec 31, 2019 | 421,000.00 |
| Sep 30, 2019 | -60,000.00 |
| Jun 30, 2019 | -61,000.00 |
| Mar 31, 2019 | -59,000.00 |
| Sep 30, 2018 | 16,000.00 |